Keith Q. Tanis, Ph.D. - Publications

Area:
Neuronal morphogenesis and degeneration; stress; schizophrenia; cell migration; cancer; metastasis; adhesion receptors

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Qin C, Tanis KQ, Podtelezhnikov AA, Glaab WE, Sistare FD, DeGeorge JJ. Toxicogenomics in drug development: a match made in heaven? Expert Opinion On Drug Metabolism & Toxicology. PMID 27050123 DOI: 10.1080/17425255.2016.1175437  0.32
2014 Arnardottir ES, Nikonova EV, Shockley KR, Podtelezhnikov AA, Anafi RC, Tanis KQ, Maislin G, Stone DJ, Renger JJ, Winrow CJ, Pack AI. Blood-gene expression reveals reduced circadian rhythmicity in individuals resistant to sleep deprivation. Sleep. 37: 1589-600. PMID 25197809 DOI: 10.5665/sleep.4064  0.32
2012 Bernard A, Lubbers LS, Tanis KQ, Luo R, Podtelezhnikov AA, Finney EM, McWhorter MM, Serikawa K, Lemon T, Morgan R, Copeland C, Smith K, Cullen V, Davis-Turak J, Lee CK, et al. Transcriptional architecture of the primate neocortex. Neuron. 73: 1083-99. PMID 22445337 DOI: 10.1016/j.neuron.2012.03.002  0.32
2012 Nikonova EV, Xiong Y, Tanis KQ, Dawson VL, Vogel RL, Finney EM, Stone DJ, Reynolds IJ, Kern JT, Dawson TM. Transcriptional responses to loss or gain of function of the leucine-rich repeat kinase 2 (LRRK2) gene uncover biological processes modulated by LRRK2 activity. Human Molecular Genetics. 21: 163-74. PMID 21972245 DOI: 10.1093/hmg/ddr451  0.32
2012 Voleti B, Tanis KQ, Newton SS, Duman RS. Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression. Biological Psychiatry. 71: 51-8. PMID 21937024 DOI: 10.1016/j.biopsych.2011.08.004  0.32
2011 Podtelezhnikov AA, Tanis KQ, Nebozhyn M, Ray WJ, Stone DJ, Loboda AP. Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging. Plos One. 6: e29610. PMID 22216330 DOI: 10.1371/journal.pone.0029610  0.32
2011 McCampbell A, Wessner K, Marlatt MW, Wolffe C, Toolan D, Podtelezhnikov A, Yeh S, Zhang R, Szczerba P, Tanis KQ, Majercak J, Ray WJ, Savage M. Induction of Alzheimer's-like changes in brain of mice expressing mutant APP fed excess methionine. Journal of Neurochemistry. 116: 82-92. PMID 21054384 DOI: 10.1111/j.1471-4159.2010.07087.x  0.32
2010 Winrow CJ, Tanis KQ, Reiss DR, Rigby AM, Uslaner JM, Uebele VN, Doran SM, Fox SV, Garson SL, Gotter AL, Levine DM, Roecker AJ, Coleman PJ, Koblan KS, Renger JJ. Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacology. 58: 185-94. PMID 19596018 DOI: 10.1016/j.neuropharm.2009.07.008  0.32
2008 Cao X, Tanis KQ, Koleske AJ, Colicelli J. Enhancement of ABL kinase catalytic efficiency by a direct binding regulator is independent of other regulatory mechanisms. The Journal of Biological Chemistry. 283: 31401-7. PMID 18796434 DOI: 10.1074/jbc.M804002200  0.32
2008 Tanis KQ, Duman RS, Newton SS. CREB binding and activity in brain: regional specificity and induction by electroconvulsive seizure. Biological Psychiatry. 63: 710-20. PMID 17936724 DOI: 10.1016/j.biopsych.2007.08.003  0.32
2007 Tanis KQ, Duman RS. Intracellular signaling pathways pave roads to recovery for mood disorders. Annals of Medicine. 39: 531-44. PMID 17852035 DOI: 10.1080/07853890701483270  0.32
2007 Tanis KQ, Newton SS, Duman RS. Targeting neurotrophic/growth factor expression and signaling for antidepressant drug development. Cns & Neurological Disorders Drug Targets. 6: 151-60. PMID 17430152 DOI: 10.2174/187152707780363276  0.32
2003 Tanis KQ, Veach D, Duewel HS, Bornmann WG, Koleske AJ. Two distinct phosphorylation pathways have additive effects on Abl family kinase activation. Molecular and Cellular Biology. 23: 3884-96. PMID 12748290 DOI: 10.1128/MCB.23.11.3884-3896.2003  0.32
Show low-probability matches.